Bill Gates giving $50 million for Alzheimer's research

November 13, 2017

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.

Gates, in an entry on his blog, said he was making the investment from his personal fortune and not with his charitable Bill & Melinda Gates Foundation.

"Of all the disorders that plague us late in life, one stands out as a particularly big threat to society: Alzheimer's disease," Gates said.

"Scientists have yet to figure out what exactly causes Alzheimer's or how to stop the disease from destroying the brain," he said. "In the United States, it is the only cause of death in the top 10 without any meaningful treatments."

Gates said he was investing $50 million in the London-based Dementia Discovery Fund, a private-public venture that supports innovative research into dementia.

The multi-billionaire philanthropist said finding for Alzheimer's, which affects nearly 50 million people worldwide, was particularly urgent since improved medical care meant people were living longer.

He noted that his own father would soon celebrate his 92nd birthday—"a milestone that was practically unimaginable when he was born."

Gates said there is a nearly 50 percent chance of developing Alzheimer's for people who live into their mid-80s.

"If you get the in your 60s or 70s, you might require expensive care for decades," he said.

"Absent a major breakthrough, expenditures will continue to squeeze healthcare budgets in the years and decades to come," Gates said.

Gates acknowledged that making progress against Alzheimer's would be a long-term project.

"The first Alzheimer's treatments might not come to fruition for another decade or more, and they will be very expensive at first," he said.

"Once that day comes, our foundation might look at how we can expand access in ," he said.

But Gates said he was optimistic.

"We've seen scientific innovation turn once-guaranteed killers like HIV into chronic illnesses that can be held in check with medication," he said. "I believe we can do the same (or better) with Alzheimer's."

The Bill & Melinda Gates Foundation has concentrated mainly on fighting communicable diseases such as malaria and polio in poor countries.

Explore further: Gates: Foundation to invest $5B in Africa over next 5 years

Related Stories

Gates: Foundation to invest $5B in Africa over next 5 years

July 17, 2016
Microsoft co-founder and philanthropist Bill Gates said Sunday his foundation will invest another $5 billion in Africa over the next five years.

Gates to focus on charity, rules out presidency

October 9, 2012
Microsoft co-founder turned global philanthropist Bill Gates said Tuesday that he will focus on charity rather than running for US presidency.

Energy innovation is focus of Gates-led $1 billion fund

December 12, 2016
Bill Gates is leading a coalition of powerful investors committing more than one billion dollars to clean energy innovations in the fight against climate change, his foundation announced Monday.

Bill Gates hopeful of AIDS vaccine in 10 years

June 26, 2015
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

Gates: $258 million for malaria research

October 31, 2005
The Bill and Melinda Gates Foundation has given $258 million in malaria research grants. The foundation says malaria kills an estimated 2,000 African children each day and takes the lives of more than 1 million people worldwide ...

Bill Gates brings far-ranging musings to the Web

January 20, 2010
(AP) -- When Bill Gates was at Microsoft's helm, his internal memos set the company's course for such radical shifts as the rise of the Internet.

Recommended for you

Study clarifies ApoE4's role in dementia

September 20, 2018
ApoE4, a protein linked to both Alzheimer's disease and a form of dementia caused by damage of blood vessels in the brain, increases the risk of cognitive impairment by reducing the number and responsiveness of blood vessels ...

Discovery could explain failed clinical trials for Alzheimer's, and provide a solution

September 19, 2018
Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed. The study also identifies a clinically ...

Machine learning IDs markers to help predict Alzheimer's

September 19, 2018
Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. These irreversible brain disorders slowly cause memory loss and destroy thinking skills, eventually to such an extent that self-care ...

Air pollution may be linked to heightened dementia risk

September 18, 2018
Air pollution may be linked to a heightened risk of developing dementia, finds a London-based observational study, published in the online journal BMJ Open. The associations found couldn't be explained by factors known to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

Study prevents cognitive decline in older blacks with memory loss

September 10, 2018
With nearly twice the rate of dementia as whites, blacks are at a higher risk for developing diseases like Alzheimer's, but there has been little research on how to reduce this racial health disparity. A new study in black ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.